Cargando…
Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262084/ https://www.ncbi.nlm.nih.gov/pubmed/34172984 http://dx.doi.org/10.1002/mco2.2 |
| _version_ | 1783540603165868032 |
|---|---|
| author | Tan, Li Kang, Xia Zhang, Bo Zheng, Shangen Liu, Bo Yu, Tiantian Yang, Fan Wang, Qiongshu Miao, Hongming |
| author_facet | Tan, Li Kang, Xia Zhang, Bo Zheng, Shangen Liu, Bo Yu, Tiantian Yang, Fan Wang, Qiongshu Miao, Hongming |
| author_sort | Tan, Li |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7262084 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72620842020-06-01 Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management Tan, Li Kang, Xia Zhang, Bo Zheng, Shangen Liu, Bo Yu, Tiantian Yang, Fan Wang, Qiongshu Miao, Hongming MedComm (2020) Letters to the Editor John Wiley and Sons Inc. 2020-05-27 /pmc/articles/PMC7262084/ /pubmed/34172984 http://dx.doi.org/10.1002/mco2.2 Text en © 2020 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Tan, Li Kang, Xia Zhang, Bo Zheng, Shangen Liu, Bo Yu, Tiantian Yang, Fan Wang, Qiongshu Miao, Hongming Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management |
| title | Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management |
| title_full | Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management |
| title_fullStr | Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management |
| title_full_unstemmed | Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management |
| title_short | Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management |
| title_sort | plasma therapy cured a covid‐19 patient with long duration of viral shedding for 49 days: the clinical features, laboratory tests, plasma therapy, and implications for public health management |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262084/ https://www.ncbi.nlm.nih.gov/pubmed/34172984 http://dx.doi.org/10.1002/mco2.2 |
| work_keys_str_mv | AT tanli plasmatherapycuredacovid19patientwithlongdurationofviralsheddingfor49daystheclinicalfeatureslaboratorytestsplasmatherapyandimplicationsforpublichealthmanagement AT kangxia plasmatherapycuredacovid19patientwithlongdurationofviralsheddingfor49daystheclinicalfeatureslaboratorytestsplasmatherapyandimplicationsforpublichealthmanagement AT zhangbo plasmatherapycuredacovid19patientwithlongdurationofviralsheddingfor49daystheclinicalfeatureslaboratorytestsplasmatherapyandimplicationsforpublichealthmanagement AT zhengshangen plasmatherapycuredacovid19patientwithlongdurationofviralsheddingfor49daystheclinicalfeatureslaboratorytestsplasmatherapyandimplicationsforpublichealthmanagement AT liubo plasmatherapycuredacovid19patientwithlongdurationofviralsheddingfor49daystheclinicalfeatureslaboratorytestsplasmatherapyandimplicationsforpublichealthmanagement AT yutiantian plasmatherapycuredacovid19patientwithlongdurationofviralsheddingfor49daystheclinicalfeatureslaboratorytestsplasmatherapyandimplicationsforpublichealthmanagement AT yangfan plasmatherapycuredacovid19patientwithlongdurationofviralsheddingfor49daystheclinicalfeatureslaboratorytestsplasmatherapyandimplicationsforpublichealthmanagement AT wangqiongshu plasmatherapycuredacovid19patientwithlongdurationofviralsheddingfor49daystheclinicalfeatureslaboratorytestsplasmatherapyandimplicationsforpublichealthmanagement AT miaohongming plasmatherapycuredacovid19patientwithlongdurationofviralsheddingfor49daystheclinicalfeatureslaboratorytestsplasmatherapyandimplicationsforpublichealthmanagement |